Tag: biopsy

For decades, the gloved-finger exam was a standard part of every man's annual physical. Now the evidence is catching up with what many doctors suspected: the digital rectal exam misses too much and finds too little. With MRI able to view the entire prostate, major guidelines have quietly pushed the old exam to the bottom of the list. keep reading

Prostate cancer has a reputation as an older man's diagnosis, yet a growing number of men in their 20s, 30s, and 40s are hearing it too. Inherited gene mutations, missed early symptoms, and lifestyle factors all feed the trend, and younger patients often face later-stage disease. Early PSA testing paired with MRI offers a powerful way to catch trouble sooner. keep reading

For decades, men have faced a coin flip after a high PSA result: biopsy or nothing. A major study of nearly 18,000 men suggests there's a smarter middle step — MRI. Used as a filter between PSA and biopsy, it identifies who truly needs further evaluation and cuts unnecessary overtreatment in half. keep reading

A high PSA result sounds alarming but it doesn't automatically mean cancer. Other factors can raise PSA, and until recently, the only way to know more was a biopsy. Now, two major breakthroughs are reshaping prostate cancer screening in ways that protect men from unnecessary procedures. keep reading

What if you could eliminate a prostate cancer tumor while keeping nearly everything else intact? That's the promise of focal therapy — and it's no longer a fringe idea. Backed by stronger imaging tools and better biopsy methods, focal therapy now delivers cancer control that rivals surgery, with far fewer side effects keep reading

Prostate cancer once looked simple. It isn't. Science now knows there are at least 15 distinct cell lines, a single tumor can harbor multiple, and each patient's cancer behaves differently. Genomic biomarker tests are changing how doctors navigate that complexity, defining risk more precisely and helping tailor treatment to the individual. keep reading

Multifocality has shaped prostate cancer treatment for years, but research shows some cases are unifocal and may qualify for less invasive focal therapy. Careful clinical evaluation is key to tailoring the best treatment approach. keep reading

Deciding on Active Surveillance for prostate cancer isn’t always straightforward. Adding genomic testing to standard factors like PSA, MRI, and biopsy can reveal hidden risks and help ensure the safest, most personalized treatment path. keep reading

Detecting prostate cancer early makes nearly 100% treatment success possible, often with fewer side effects. Routine PSA screening and modern imaging tools help identify cancer while it's still most curable. Skipping annual tests risks missing the critical window for best outcomes. keep reading

Artificial Intelligence is reshaping prostate cancer care, from more accurate screening and early detection to optimizing treatment strategies. New research highlights four major clinical areas where AI is already making a measurable difference in diagnosis, risk assessment, and therapy planning. keep reading